North America Disposable Infusion Sets Market to Reach USD 723.07 Million by 2035, Growing from USD 495.00 Million in 2025 - SRI

London, UK - October 2026 | Strategic Revenue Insights Inc. - Ageing patients and chronic disease, the shift to outpatient infusion, infection control rules and pump compatible sets are supporting steady growth in disposable infusion sets across North America.

https://www.strategicrevenueinsights.com/industry/north-america-disposable-infusion-sets-market

The North America Disposable Infusion Sets market was valued at USD 495.00 million in 2025 and is projected to reach USD 723.07 million by 2035, growing at a CAGR of 3.9%, according to Strategic Revenue Insights Inc. The report was prepared by lead analyst Rohan Mehta. The research methodology combines primary interviews with relevant industry stakeholders, including infusion set manufacturers, hospitals, ambulatory surgical centers and home healthcare providers, with secondary data across the regions covered by the report.

KEY TAKEAWAYS

Market value is projected to rise from USD 495.00 million in 2025 to USD 723.07 million by 2035, at a CAGR of 3.9%.

Gravity Infusion Sets are the largest type with a 46.00% share, while Pump Infusion Sets are the fastest-growing type at a 5.2% CAGR.

Tubing is the largest component at 38.00% while Flow Regulators grow fastest at 4.3%, and Hospitals are the largest end user at 62.00% while Home Healthcare grows fastest at 5.2%.

The United States is the largest country market with an 80.00% share, valued at USD 396.00 million in 2025, while Mexico is the fastest-growing of the three largest country markets at a 4.7% CAGR.

Named market participants include Becton Dickinson, ICU Medical, and Baxter International.

Full report access: https://www.strategicrevenueinsights.com/industry/north-america-disposable-infusion-sets-market

GROWTH DRIVERS AND TRENDS

Ageing patients and chronic disease are the largest growth driver, adding an estimated 1.6 percentage points to the CAGR, followed by the shift to outpatient infusion at 1.2 points, infection control rules at 0.9 points, and pump compatible sets at 0.7 points. The source projects the market at USD 599.35 million in 2030.

Trends described in the report include the shift from gravity to pump infusion, the shift from inpatient to outpatient and home care, conversion to DEHP-free tubing, domestic manufacturing and supply security as a selling point, and kit-based offers for outpatient and home settings. 2035 scenarios range from USD 640.00 million to USD 810.00 million.

MARKET SEGMENTATION

By type, the market is segmented into Gravity Infusion Sets (46.00%), Pump Infusion Sets (36.00%), Burette Infusion Sets (10.50%), and Blood Infusion Sets (7.50%). Gravity Infusion Sets is the largest segment with a 2.9% CAGR, rising from USD 227.70 million to USD 304.52 million, and Pump Infusion Sets is the fastest-growing at 5.2%, rising from USD 178.20 million to USD 294.47 million.

By component, the market covers Tubing (38.00%), Drip Chamber (24.00%), Flow Regulator (20.00%), and Needle and Connector (18.00%). Tubing is the largest segment with a 4.0% CAGR, and Flow Regulator is the fastest-growing at 4.3%.

By end user, the market includes Hospitals (62.00%), Ambulatory Surgical Centers (14.50%), Clinics (12.50%), and Home Healthcare (11.00%). Hospitals is the largest segment with a 3.4% CAGR, and Home Healthcare is the fastest-growing at 5.2%, followed by Ambulatory Surgical Centers at 4.6%.

REGIONAL OUTLOOK

The report covers the United States, Canada, Mexico, the Dominican Republic, Guatemala, Costa Rica, Panama, and the Rest of North America. The United States is the largest country market with an 80.00% share, valued at USD 396.00 million in 2025 and projected to reach USD 569.49 million by 2035 at a 3.7% CAGR. Canada holds 8.00% (USD 39.60 million, rising to USD 57.50 million) with a 3.8% CAGR, and Mexico 6.00% (USD 29.70 million, rising to USD 47.01 million) with 4.7%. The Dominican Republic (0.60%, USD 2.97 million), Guatemala (0.50%, USD 2.48 million), Costa Rica (0.50%, USD 2.48 million) and Panama (0.40%, USD 1.98 million) each grow at 3.9%, and the Rest of North America (4.00%, USD 19.79 million rising to USD 34.56 million) grows at 5.7%.

COMPETITIVE LANDSCAPE

The report profiles Becton Dickinson (US, 14.0% share), which supplies IV administration sets that pair with its infusion pumps and needle-free connectors; ICU Medical (US, 12.0%), which sells gravity and pump administration sets and connectors; Baxter International (US, 10.0%), which produces administration sets sold alongside its IV solutions and pumps; B. Braun (Germany, 8.0%), which offers PVC-free and DEHP-free sets for its pumps with US manufacturing; Cardinal Health (US, 6.0%), which distributes private label gravity and extension sets through its hospital supply channel; and Fresenius Kabi (Germany, 5.0%), which supplies sets for its pumps and for parenteral nutrition and drug delivery. Terumo (4.0%), Medtronic, Nipro and Amsino International are also covered.

MARKET RESTRAINTS

Hospital cost pressure reduces the CAGR by an estimated 0.8 percentage points, and supply and plastics risk subtracts a further 0.6 points. The report also cites hospital pressure on unit prices, resin cost swings, the DEHP phase-out, tariff exposure on imported tubing, and ethylene oxide sterilization capacity and emissions rules.

RELATED REPORTS

https://www.strategicrevenueinsights.com/industry/europe-orthopedic-devices-market

https://www.strategicrevenueinsights.com/industry/asia-pacific-orthopedic-devices-market

https://www.strategicrevenueinsights.com/industry/radioligand-therapy-market

https://www.strategicrevenueinsights.com/industry/fill-finish-services-market

https://www.strategicrevenueinsights.com/industry/hospital-at-home-market

https://www.strategicrevenueinsights.com/industry/ai-medical-scribe-market

https://www.strategicrevenueinsights.com/industry/north-america-orthopedic-devices-market

https://www.strategicrevenueinsights.com/industry/in-vivo-car-t-therapy-market

https://www.strategicrevenueinsights.com/industry/ai-drug-repurposing-market

https://www.strategicrevenueinsights.com/industry/antimicrobial-medical-textiles-market

FREQUENTLY ASKED QUESTIONS

What is the North America Disposable Infusion Sets market size in 2025?

The market was valued at USD 495.00 million in 2025.

What is the North America Disposable Infusion Sets market forecast for 2035?

The market is projected to reach USD 723.07 million by 2035, growing at a CAGR of 3.9%.

Which segment is largest in the North America Disposable Infusion Sets market?

Gravity Infusion Sets is the largest type with a 46.00% share, and Hospitals is the largest end user with a 62.00% share.

Which region leads the North America Disposable Infusion Sets market?

The United States is the largest country market with an 80.00% share, valued at USD 396.00 million in 2025 and projected to reach USD 569.49 million by 2035 at a 3.7% CAGR. Canada holds 8.00% (USD 39.60 million, rising to USD 57.50 million) with a 3.8% CAGR, and Mexico 6.00% (USD 29.70 million, rising to USD 47.01 million) with 4.7%. The Dominican Republic (0.60%, USD 2.97 million), Guatemala (0.50%, USD 2.48 million), Costa Rica (0.50%, USD 2.48 million) and Panama (0.40%, USD 1.98 million) each grow at 3.9%, and the Rest of North America (4.00%, USD 19.79 million rising to USD 34.56 million) grows at 5.7%.

MEDIA CONTACT INFORMATION
Company Name: Strategic Revenue Insights Inc.
Contact Person: Rohit Bhisey
Email: sales@strategicrevenueinsights.com
Phone: +44 7877403352
Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL
City: London
State: London
Country: United Kingdom

Strategic Revenue Insights Inc.
Rohit Bhisey
Suite 10, Capital House, 61 Amhurst Road, E8 1LL
London, United Kingdom
sales@strategicrevenueinsights.com
+44 7877403352

Strategic Revenue Insights Inc., a distinguished subsidiary of SRI Consulting Group Ltd, stands as a premier provider of data-driven market intelligence, empowering organizations globally to navigate complex business landscapes with confidence and precision. Headquartered in London, United Kingdom, our firm specializes in delivering comprehensive syndicated research reports, bespoke consulting solutions, and actionable strategic insights that enable clients to make informed, forward-thinking decisions in an increasingly competitive marketplace.

Our dedicated team of accomplished analysts, strategically positioned in London with an extensive global network, maintains continuous vigilance over evolving market dynamics, identifying emerging trends and uncovering high-potential growth opportunities that drive sustained client success. As an integral component of SRI Consulting Group Ltd, we uphold unwavering commitments to analytical accuracy, clarity of presentation, and practical applicability, assisting organizations in navigating competitive terrain, optimizing strategic initiatives, and accelerating revenue trajectories.

Through the integration of rigorous research methodologies with profound industry expertise, Strategic Revenue Insights Inc. delivers comprehensive market perspectives that generate measurable outcomes and establish enduring competitive advantages for our clients across diverse sectors and geographies.

Corporate Websites:
www.strategicrevenueinsights.com
www.strategicpackaginginsights.com
www.sriconsultinggroupltd.com
https://strategicrevenueinsights.blog/
https://medium.com/@strategic-revenue-insights.inc
https://www.strategicrevenueinsights.com/press-releases

This release was published on openPR.